Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial
Huang, Liang, Pang, Da, Yang, Hongjian, Li, Wei, Wang, Shusen, Cui, Shude, Liao, Ning, Wang, Yongsheng, Wang, Chuan, Chang, Yuan-Ching, Wang, Hwei-Chung, Kang, Seok Yun, Seo, Jae Hong, Shen, Kunwei, Laohawiriyakamol, Suphawat, Jiang, Zefei, Wang, Haiyan, Lamour, François, Song, Grace, Curran, Michelle, Duan, Chunzhe, Lysbet de Haas, Sanne, Restuccia, Eleonora, Shao, Zhimin
Published in Nature communications (09.03.2024)
Published in Nature communications (09.03.2024)
Get full text
Journal Article
Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular Complications
Niesor, Eric J, Nader, Elie, Perez, Anne, Lamour, François, Benghozi, Renée, Remaley, Alan, Thein, Swee Lay, Connes, Philippe
Published in Membranes (Basel) (01.11.2022)
Published in Membranes (Basel) (01.11.2022)
Get full text
Journal Article
Effects of in vivo chronic exposure to pendimethalin/Prowl 400® on sanitary status and the immune system in rainbow trout (Oncorhynchus mykiss)
Danion, Morgane, Le Floch, Stéphane, Kanan, Rami, Lamour, François, Quentel, Claire
Published in The Science of the total environment (01.05.2012)
Published in The Science of the total environment (01.05.2012)
Get full text
Journal Article
EROD activity and antioxidant defenses of sea bass (Dicentrarchus labrax) after an in vivo chronic hydrocarbon pollution followed by a post-exposure period
Danion, Morgane, Floch, Stéphane Le, Lamour, François, Quentel, Claire
Published in Environmental science and pollution research international (01.12.2014)
Published in Environmental science and pollution research international (01.12.2014)
Get full text
Journal Article
Effect of chronic exposure to pendimethalin on the susceptibility of rainbow trout, Oncorhynchus mykiss L., to viral hemorrhagic septicemia virus (VHSV)
Danion, Morgane, Le Floch, Stéphane, Castric, Jeanne, Lamour, François, Cabon, Joëlle, Quentel, Claire
Published in Ecotoxicology and environmental safety (01.05.2012)
Published in Ecotoxicology and environmental safety (01.05.2012)
Get full text
Journal Article
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
Zeuzem, Stefan, Diago, Moisés, Gane, Edward, Reddy, K Rajender, Pockros, Paul, Prati, Daniele, Shiffman, Mitchell, Farci, Patrizia, Gitlin, Norman, O'Brien, Christopher B, Lamour, François, Lardelli, Pilar
Published in Gastroenterology (New York, N.Y. 1943) (01.12.2004)
Published in Gastroenterology (New York, N.Y. 1943) (01.12.2004)
Get more information
Journal Article
Abstract PD18-03: Final analysis of the Phase III PEONY trial: long-term efficacy and safety of neoadjuvant–adjuvant pertuzumab or placebo, plus trastuzumab and docetaxel, in patients with HER2-positive early or locally advanced breast cancer
Shao, Zhi-Ming, Pang, Da, Yang, Hongjian, Li, Wei, Wang, Shusen, Cui, Shude, Liao, Ning, Wang, Yong-Sheng, Wang, Chuan, Chang, Yuan-Ching, Wang, Hwei-Chung, Kang, Seok Yun, Seo, Jae Hong, Shen, Kunwei, Laohawiriyakamol, Suphawat, Jiang, Zefei, Huang, Liang, Wang, Haiyan, Lamour, François, Song, Grace, Restuccia, Eleonora
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Primary results of ELAINA: a randomized, multicenter, open-label, phase III study of the efficacy and safety of trastuzumab emtansine vs. lapatinib plus capecitabine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy
Wang, Xiaojia, Li, Wei, Yin, Yongmei, Tong, Zhongsheng, Zhang, Qingyuan, Zheng, Hong, Shao, Zhimin, Li, Huiping, Yang, Jin, Feng, Jifeng, Wu, Fan, Lamour, Francois, Restuccia, Eleonora, Jiang, Zefei
Published in Translational breast cancer research : a journal focusing on translational research in breast cancer (2023)
Published in Translational breast cancer research : a journal focusing on translational research in breast cancer (2023)
Get more information
Journal Article